140 related articles for article (PubMed ID: 9122971)
21. Enalapril treatment of posttransplant erythrocytosis: efficacy independent of circulating erythropoietin levels.
Perazella M; McPhedran P; Kliger A; Lorber M; Levy E; Bia MJ
Am J Kidney Dis; 1995 Sep; 26(3):495-500. PubMed ID: 7645558
[TBL] [Abstract][Full Text] [Related]
22. Correction of posttransplant erythrocytosis with enalapril.
Rell K; Koziak K; Jarzyo I; Lao M; Gaciong Z
Transplantation; 1994 Apr; 57(7):1059-63. PubMed ID: 8165703
[TBL] [Abstract][Full Text] [Related]
23. Role of ACE inhibitors in the treatment of erythrocytosis in patients with renal allograft.
Pisani F; Tisone G; Alciati E; Vennarecci G; Pieragostini E; Casciani CU
Transplant Proc; 1994 Oct; 26(5):2602-3. PubMed ID: 7940809
[No Abstract] [Full Text] [Related]
24. Usefulness and safety of treatment with captopril in posttransplant erythrocytosis.
Hernández E; Morales JM; Andrés A; Ortuño B; Praga M; Alcazar JM; Fernández G; Rodicio JL
Transplant Proc; 1995 Aug; 27(4):2239-41. PubMed ID: 7652789
[No Abstract] [Full Text] [Related]
25. Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis.
Glicklich D; Burris L; Urban A; Tellis V; Greenstein S; Schechner R; Devarajan P; Croizat H
J Am Soc Nephrol; 2001 Sep; 12(9):1958-1964. PubMed ID: 11518790
[TBL] [Abstract][Full Text] [Related]
26. Posttransplant erythrocytosis: an enigma revisited.
Gaston RS; Julian BA; Curtis JJ
Am J Kidney Dis; 1994 Jul; 24(1):1-11. PubMed ID: 8023814
[TBL] [Abstract][Full Text] [Related]
27. Enalapril: safe and effective therapy for posttransplant erythrocytosis.
Gaston RS; Julian BA; Barker CV; Diethelm AG; Curtis JJ
Transplant Proc; 1993 Feb; 25(1 Pt 2):1029-31. PubMed ID: 8442029
[No Abstract] [Full Text] [Related]
28. Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Clinical experience and observation of mechanism.
Danovitch GM; Jamgotchian NJ; Eggena PH; Paul W; Barrett JD; Wilkinson A; Lee DB
Transplantation; 1995 Jul; 60(2):132-7. PubMed ID: 7624954
[TBL] [Abstract][Full Text] [Related]
29. Early posttransplant erythrocytosis in renal allograft recipients.
Prakash J; Singh S; Behur SK; Ghosh B; Sharatchandra LK; Dwivedi US
J Assoc Physicians India; 2010 Sep; 58():574-6. PubMed ID: 21391381
[TBL] [Abstract][Full Text] [Related]
30. Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients.
Kupin W; Venkat KK; Goggins M; Abouljoud M; Escobar F; Mozes M
Transplant Proc; 1997; 29(1-2):207-8. PubMed ID: 9122965
[No Abstract] [Full Text] [Related]
31. Effect of enalapril on exaggerated erythropoietin response to phlebotomy in erythrocytosic renal transplant patients.
Usalan C; Erdem Y; Cağlar M; Altun B; Arici M; Bakkaloğlu M; Yasavul U; Turgan C; Cağlar S
Nephrol Dial Transplant; 1998 Nov; 13(11):2884-9. PubMed ID: 9829495
[TBL] [Abstract][Full Text] [Related]
32. Treatment of postrenal transplant erythrocytosis. Long-term efficacy and safety of angiotensin-converting enzyme inhibitors.
MacGregor MS; Rowe PA; Watson MA; Rodger RS; Junor BJ; Briggs JD
Nephron; 1996; 74(3):517-21. PubMed ID: 8938674
[TBL] [Abstract][Full Text] [Related]
33. Postrenal transplant erythrocytosis: the roles of testosterone and erythropoietin.
Demiroğlu H
Clin Nephrol; 1997 Apr; 47(4):279. PubMed ID: 9128802
[No Abstract] [Full Text] [Related]
34. The effect of losartan on posttransplant erythrocytosis.
Colak T; Emiroglu R; Karakayali H; Haberal M
Transplant Proc; 2001; 33(1-2):2014-5. PubMed ID: 11267606
[No Abstract] [Full Text] [Related]
35. Ramipril in post-renal transplant erythrocytosis.
Esposito R; Giammarino A; De Blasio A; Martinelli V; Cirillo F; Scopacasa F; Federico S; Russo D
J Nephrol; 2007; 20(1):57-62. PubMed ID: 17347974
[TBL] [Abstract][Full Text] [Related]
36. A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis.
Trivedi H; Lal SM
Ren Fail; 2003 Jan; 25(1):77-86. PubMed ID: 12617335
[TBL] [Abstract][Full Text] [Related]
37. Posttransplant erythrocytosis.
Vlahakos DV; Marathias KP; Agroyannis B; Madias NE
Kidney Int; 2003 Apr; 63(4):1187-94. PubMed ID: 12631334
[TBL] [Abstract][Full Text] [Related]
38. Blockade of angiotensin II AT 1 receptor reduces hematocrit in patients with posttransplant erythrocytosis.
Tsang WK; Tong KL; Chan HW
Transplant Proc; 1998 Nov; 30(7):3072-3. PubMed ID: 9838354
[No Abstract] [Full Text] [Related]
39. [Erythrocytosis post kidney transplantation and its pharmacological treatment: angiotensin converting enzyme inhibitors or angiotensin receptor blockers in a case].
Duclos J
Rev Med Chil; 2000 Feb; 128(2):211-2. PubMed ID: 10962891
[TBL] [Abstract][Full Text] [Related]
40. Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: efficacy, safety and action mechanisms.
Montanaro D; Groupuzzo M; Boscutti G; Risaliti A; Bresadola F; Mioni G
Clin Nephrol; 2000 Apr; 53(4):suppl 47-51. PubMed ID: 10809436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
